Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|November 19, 2024
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinomaShereen Ezzat, Jesse D Pasternak, Murali Rajaraman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinomaAlec J Kacew, Ethan J Harris, Jochen H Lorch, et al.
Head & Neck Oncology|March 1, 2011
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neckNicole G Chau, Bayardo Perez-Ordonez, Katherine Zhang, et al.
Oral Oncology|September 24, 2017
Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapyDanielle N Margalit, Jonathan D Schoenfeld, Bhupendra Rawal, et al.
JCI Insight|February 23, 2018
Frameshift events predict anti-PD-1/L1 response in head and neck cancerGlenn J Hanna, Patrick Lizotte, Megan Cavanaugh, et al.
Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinomaGlenn J Hanna, Vishwajith Sridharan, Danielle N Margalit, et al.
Head & Neck|December 20, 2021
Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomesKevin Tyan, Ji Eun Bae, Jochen H Lorch, et al.
Cancer Immunology Research|June 18, 2016
Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating LymphocytesVishwajith Sridharan, Evisa Gjini, Xiaoyun Liao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid TumorsVandana G Abramson, Jeffrey G Supko, Tarah Ballinger, et al.
The Oncologist|April 21, 2020
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland CancersGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Pageof 5